New Cell Phone Study Says Hang Up And Use a Land Line
http://www.seventhgeneration.com/learn/blog/new-cell-phone-study-says-hang-use-land-line
Informant: Art Kab
Informant: Art Kab
Starmail - 16. Mai, 08:54
16
Mai
2008
Chromosomal radiosensitivity in head and neck cancer patients: evidence for genetic predisposition?
Br J Cancer. 2008 May 20;98(10):1723-38. Epub 2008 Apr 15.
De Ruyck K, de Gelder V, Van Eijkeren M, Boterberg T, De Neve W, Vral A, Thierens H.
1Department of Human Anatomy, Embryology, Histology and Medical Physics, Ghent University, Proeftuinstraat 86, Ghent B-9000, Belgium.
The association between chromosomal radiosensitivity and genetic predisposition to head and neck cancer was investigated in this study. In all, 101 head and neck cancer patients and 75 healthy control individuals were included in the study. The G(2) assay was used to measure chromosomal radiosensitivity. The results demonstrated that head and neck cancer patients had a statistically higher number of radiation-induced chromatid breaks than controls, with mean values of 1.23 and 1.10 breaks per cell, respectively (P<0.001). Using the 90th percentile of the G(2) scores of the healthy individuals as a cutoff value for chromosomal radiosensitivity, 26% of the cancer patients were radiosensitive compared with 9% of the healthy controls (P=0.008). The mean number of radiation-induced chromatid breaks and the proportion of radiosensitive individuals were highest for oral cavity cancer patients (1.26 breaks per cell, 38%) and pharynx cancer patients (1.27 breaks per cell, 35%). The difference between patients and controls was most pronounced in the lower age group (</=50 years, 1.32 breaks per cell, 38%) and in the non- and light smoking patient group (</=10 pack-years, 1.28 breaks per cell, 46%). In conclusion, enhanced chromosomal radiosensitivity is a marker of genetic predisposition to head and neck cancer, and the genetic contribution is highest for oral cavity and pharynx cancer patients and for early onset and non- and light smoking patients.British Journal of Cancer (2008) 98, 1723-1738. doi:10.1038/sj.bjc.6604345 www.bjcancer.com Published online 15 April 2008.
PMID: 18414410 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/18414410
Informant: Martin Weatherall
De Ruyck K, de Gelder V, Van Eijkeren M, Boterberg T, De Neve W, Vral A, Thierens H.
1Department of Human Anatomy, Embryology, Histology and Medical Physics, Ghent University, Proeftuinstraat 86, Ghent B-9000, Belgium.
The association between chromosomal radiosensitivity and genetic predisposition to head and neck cancer was investigated in this study. In all, 101 head and neck cancer patients and 75 healthy control individuals were included in the study. The G(2) assay was used to measure chromosomal radiosensitivity. The results demonstrated that head and neck cancer patients had a statistically higher number of radiation-induced chromatid breaks than controls, with mean values of 1.23 and 1.10 breaks per cell, respectively (P<0.001). Using the 90th percentile of the G(2) scores of the healthy individuals as a cutoff value for chromosomal radiosensitivity, 26% of the cancer patients were radiosensitive compared with 9% of the healthy controls (P=0.008). The mean number of radiation-induced chromatid breaks and the proportion of radiosensitive individuals were highest for oral cavity cancer patients (1.26 breaks per cell, 38%) and pharynx cancer patients (1.27 breaks per cell, 35%). The difference between patients and controls was most pronounced in the lower age group (</=50 years, 1.32 breaks per cell, 38%) and in the non- and light smoking patient group (</=10 pack-years, 1.28 breaks per cell, 46%). In conclusion, enhanced chromosomal radiosensitivity is a marker of genetic predisposition to head and neck cancer, and the genetic contribution is highest for oral cavity and pharynx cancer patients and for early onset and non- and light smoking patients.British Journal of Cancer (2008) 98, 1723-1738. doi:10.1038/sj.bjc.6604345 www.bjcancer.com Published online 15 April 2008.
PMID: 18414410 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/18414410
Informant: Martin Weatherall
Starmail - 16. Mai, 06:02
